Morbidity and mortality after stroke--eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).

Source:http://linkedlifedata.com/resource/pubmed/id/16397169

Download in:

View as

General Info

PMID
16397169